I'm sure most would have read the ANN where it stated that 1/4 dose sales will no longer be published.
We have the fluffy story about concentrating on the 2020 vision, but there is no cost to SRX in publishing this data, so what are the views out there as to why this reduction in measurable data?
No more 1/4 dose sales
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.3¢ |
Change
-0.003(1.61%) |
Mkt cap ! $64.72M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.5¢ | 15.0¢ | $58.98K | 380.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 2627800 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 80934 | 5 |
View Market Depth
| Last trade - 15.59pm 10/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |